Entrada Therapeutics, Inc. (TRDA)
13.56
-0.43
(-3.07%)
USD |
NASDAQ |
Apr 16, 16:00
13.53
-0.03
(-0.22%)
After-Hours: 20:00
Entrada Therapeutics Market Cap : 519.14M for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tyra Biosciences, Inc. | 1.892B |
| Biogen, Inc. | 25.83B |
| EyePoint Plc | 1.236B |
| Vertex Pharmaceuticals, Inc. | 110.67B |
| Arcutis Biotherapeutics, Inc. | 3.000B |
Market Cap Related Metrics
| PS Ratio | 22.07 |
| Price to Book Value | 1.696 |
| Price | 13.56 |
| Earnings Yield | -25.60% |